Tag: Zhu Ke
Luzhu Biotechnology launches HKD341m IPO via chapter 18A
Luzhu Biotechnology debuted on the HKEX through chapter 18A, the first biotech company without any revenue or profits to be listed this year, raising USD43.45 million
O’Melveny acts on Acotec Scientific’s partial offering
O’Melveny advised China’s medical technology company, Acotec Scientific Holdings, on the voluntary partial offer for a majority stake of up to 65% by US-listed Boston Scientific Group
